Virtu Financial’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,278
| Closed | -$91K | – | 1619 |
|
|
2022
Q1 | $91K | Buy |
11,278
+3,197
| +40% | +$25.8K | 0.01% | 995 |
|
|
2021
Q4 | $65K | Buy |
8,081
+5,025
| +164% | +$40.4K | 0.01% | 1264 |
|
|
2021
Q3 | $36K | Buy |
+3,056
| New | +$36K | ﹤0.01% | 1315 |
|
|
2021
Q2 | – | Sell |
-6,611
| Closed | -$159K | – | 1550 |
|
|
2021
Q1 | $159K | Buy |
6,611
+5,366
| +431% | +$129K | 0.01% | 1169 |
|
|
2020
Q4 | $37K | Sell |
1,245
-2,605
| -68% | -$77.4K | ﹤0.01% | 1278 |
|
|
2020
Q3 | $59K | Buy |
+3,850
| New | +$59K | 0.01% | 801 |
|
|
2018
Q1 | – | Sell |
-1,212
| Closed | -$39K | – | 2000 |
|
|
2017
Q4 | $39K | Sell |
1,212
-2,867
| -70% | -$92.3K | ﹤0.01% | 2114 |
|
|
2017
Q3 | $72K | Buy |
+4,079
| New | +$72K | ﹤0.01% | 2155 |
|